3 results
Approved WMOCompleted
Our study aim is to assess whether it is feasible to remove small breast cancers completely using the BLES system under US guidance.
Approved WMOCompleted
In this study we will investigate how quickly and to what extent ralmitaront is absorbed, transported, and eliminated from the body (this is called pharmacokinetics). Ralmitaront is radioactively labelled with carbon 14 (14C). In this way…
Approved WMORecruiting
The aim of this study is to assess the efficacy of MR-HIFU as a treatment modality for desmoid-type fibromatosis (DTF).